Bymetric
UK company intelligence
Company Active LTD

Company profile

Id Business Solutions Limited

UK company 02414430, incorporated on 17 August 1989.

Home - IDBS Industrys Trusted Partner for Digital Enablement

IDBS is the global leader of integrated, enterprise-wide R&D informatics platform - in the cloud. Proven in over 30 industries.

Company number
02414430
Incorporated
17 Aug 1989
Companies House status
Active

Company identity

Founded / incorporated
17 August 1989

Company number 02414430

Verify at Companies House
Legal name
ID BUSINESS SOLUTIONS LIMITED
Company type
LTD
Region
South East England
Registered address
Unknown
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

7 levels 1 ultimate controller Controls 2
1
Company Active LTD
Id Business Solutions Limited
CRN 02414430
2
Direct controller Active LTD
Launchchange Operations Limited
CRN 07105768
3
Intermediate controller Active LTD
Launchchange Limited
CRN 02639894
4
Intermediate controller Active LTD
Launchchange UK Holdco Limited
CRN 13738808
5
Intermediate controller Active LTD
Launchchange Instrumentation Limited
CRN 02330973
6
Intermediate controller Active PRIVATE-UNLIMITED
VR Finance Company
CRN 03428240
7
Intermediate controller Active PRIVATE-UNLIMITED
Launchchange Holding Company
CRN 03259276
8
Ultimate controller
02103594
CRN 02103594

Company events

Reference milestones and recent Companies House filing stream events.

2 events
15 Jul
2026

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzUzMDc2NzYxMmFkaXF6a2N4 | Paper/PDF filed

Published 15 Jul 2026 13:10

17 Aug
1989

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2011
Funded years
2011
Age at first award
22 years

Projects

2011 Collaborative R&D Lead participant

Acropolis (Advanced Collaborative Research for Oncology Platform for Improved Outcomes, Learnings, Insight and Science)

1 Oct 2011 to 30 Jun 2014

Awarded
£749,520
Total cost £2,089,911

Growing healthcare costs and poor patient outcomes is driving increased interest in collaboration to support stratified medicines as a means to deliver targeted, safe and cost effective treatments. Research into stratified medicines is severely curtailed by poor access to high quality patient data and the deluge in associated genetic, molecular and image ...

Product types

Collaborative R&D